Published in Drug Week, September 8th, 2006
According to a study from the United States and Canada , "The co-administration of prescription omega-3-acid ethyl esters (P-OM3) with a statin may present a treatment option for patients with mixed hyperlipidemia. This open-label, randomized, two-way crossover, drug-drug interaction study evaluated the impact of P-OM3 capsules on plasma simvostatin pharmacokinetics in 24 healthy volunteers."
"Under fasted conditions, 80 mg simvastatin was administered with or without 4 g...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.